tiprankstipranks
Longeveron appoints Wa’el Hashad as Chief Executive Officer
The Fly

Longeveron appoints Wa’el Hashad as Chief Executive Officer

Longeveron announced the appointment of global pharmaceutical leader Wa’el Hashad as Chief Executive Officer. Hashad will assume the role of Chief Executive Officer effective March 1, 2023. Following Hashad joining Longeveron, current Interim Chief Executive Officer Chris Min, M.D., Ph.D., will continue in his role as Chief Medical Officer. Hashad brings to Longeveron over 35 years of leadership in global pharmaceutical and biotechnology companies. Most recently, he was President and Chief Executive Officer at Avanir Pharmaceuticals.

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on LGVN:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles